Ongoing challenges and promising new developments in HIV treatment

While promising developments are in the pipeline, barriers still remain - particularly in measuring efficacy of new developments with PrEP the standard of care.

Stephen Schrantz, MD and Senior Director of Medical Strategy at IQVIA, explores these barriers and unveils promising developments in research, including:

Challenges in global research - measuring drug efficacy to patient recruitment
Examining the slow global uptake of PrEP
Innovative prevention methods, such as lenacapavir
Improving public education on risks of HIV
Key global initiatives

Download the Whitepaper

Your company email address

Please select your industry: (max 1)
Yes, I would like to be contacted by an IQVIA expert

Opt In?

Berne Media may store and process my information. For details, see the Privacy Notice.
Citeline (previously Pharma Intelligence UK) may contact me with updates, relevant promotions and information about products. My Information will be used in accordance with the Citeline Privacy Policy, and you withdraw your permission to receive any of our communications at any time.
By clicking submit, you consent to allow IQVIA to store and process the information submitted to provide you the content requested. They are subject to IQVIA Terms and Conditions.

Ongoing challenges and promising new developments in HIV treatment

Download the Whitepaper

Opt In?

Explore similar content

Safety & Regulatory Compliance Predictions For 2025

Maximizing value across drug development: Embracing a new CDMO and CRO partnership approach

Getting The Most Out Of Your Lab Space